Repurposing Drugs for New Indications: Benefits and Challenges
Summary: In a webinar hosted by Endpoints News, executives from Catalent Biologics, Humanigen and WYSS Institute shared diverse insights about challenges and opportunities with repurposing drugs for new disease treatments. Rather than starting from scratch, drug repurposing screens approved therapies, and even unapproved therapies, to identify new therapeutic indications for rare and common diseases.